Literature DB >> 16408861

Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues.

Ugo Bilati1, Eric Allémann, Eric Doelker.   

Abstract

The goal of this study was to investigate the entrapment of 3 different model proteins (tetanus toxoid, lysozyme, and insulin) into poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) nanoparticles and to address process-related stability issues. For that purpose, a modified nanoprecipitation method as well as 2 emulsion-based encapsulation techniques (ie, a solid-in oil-in water (s/o/w) and a double emulsion (w(1)/o/w(2)) method) were used. The main modification of nanoprecipitation involved the use of a wide range of miscible organic solvents such as dimethylsulfoxide and ethanol instead of the common acetone and water. The results obtained showed that tetanus toxoid and lysozyme were efficiently incorporated by the double emulsion procedure when ethyl acetate was used as solvent (>80% entrapment efficiency), whereas it was necessary to use methylene chloride to achieve high insulin entrapment efficiencies. The use of the s/o/w method or the formation of a more hydrophobic protein-surfactant ion pair did not improve protein loading. The nanoprecipitation method led to a homogenous population of small nanoparticles (with size ranging from approximately 130 to 560 nm) and in some cases also improved experimental drug loadings, especially for lysozyme (entrapment efficiency > 90%). With respect to drug content determination, a simple and quick matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) method provided results very close to those obtained by reverse phase-high-performance liquid chromatography. With respect to protein stability, the duration and intensity of sonication were not a concern for tetanus toxoid, which retained more than 95% of its antigenicity after treatment for 1 minute. Only a high methylene chloride:water ratio was shown to slightly decrease toxoid antigenicity. Finally, no more than 3.3% of A21 desamido insulin and only traces of covalent insulin dimer were detected in nanoparticles. In conclusion, both the double emulsion and nanoprecipitation methods allowed efficient protein encapsulation. MALDI-TOF MS allowed accurate drug content determination. The manufacturing processes evaluated did not damage the primary structure of insulin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16408861      PMCID: PMC2750607          DOI: 10.1208/pt060474

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  35 in total

1.  Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.

Authors:  Yilmaz Capan; Ge Jiang; Stefano Giovagnoli; Kyu-Heum Na; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

Review 2.  Hydrophobic ion pairing: altering the solubility properties of biomolecules.

Authors:  J D Meyer; M C Manning
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

3.  Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method.

Authors:  T Uchida; N Nagareya; S Sakakibara; Y Konishi; A Nakai; M Nishikata; K Matsuyama; K Yoshida
Journal:  Chem Pharm Bull (Tokyo)       Date:  1997-09       Impact factor: 1.645

4.  Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.

Authors:  R K Gupta; A C Chang; P Griffin; R Rivera; Y Y Guo; G R Siber
Journal:  Vaccine       Date:  1997 Apr-May       Impact factor: 3.641

5.  Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method--processing and formulation issues for enhanced entrapment efficiency.

Authors:  U Bilati; E Allémann; E Doelker
Journal:  J Microencapsul       Date:  2005-03       Impact factor: 3.142

6.  A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.

Authors:  M Tobío; J Nolley; Y Guo; J McIver; M J Alonso
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

7.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles.

Authors:  Ugo Bilati; Carla Pasquarello; Garry L Corthals; Denis F Hochstrasser; Eric Allémann; Eric Doelker
Journal:  J Pharm Sci       Date:  2005-03       Impact factor: 3.534

8.  Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.

Authors:  Y Kawashima; H Yamamoto; H Takeuchi; S Fujioka; T Hino
Journal:  J Control Release       Date:  1999-11-01       Impact factor: 9.776

9.  Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles.

Authors:  H S Yoo; H K Choi; T G Park
Journal:  J Pharm Sci       Date:  2001-02       Impact factor: 3.534

10.  Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.

Authors:  T Uchida; A Yagi; Y Oda; Y Nakada; S Goto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1996-01       Impact factor: 1.645

View more
  30 in total

1.  Improved enzyme activity and stability in polymer microspheres by encapsulation of protein nanospheres.

Authors:  Brenda L Montalvo-Ortiz; Brian Sosa; Kai Griebenow
Journal:  AAPS PharmSciTech       Date:  2012-04-27       Impact factor: 3.246

Review 2.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

3.  Nanoprecipitation is more efficient than emulsion solvent evaporation method to encapsulate cucurbitacin I in PLGA nanoparticles.

Authors:  Aws Alshamsan
Journal:  Saudi Pharm J       Date:  2013-12-14       Impact factor: 4.330

4.  Whole-animal imaging and flow cytometric techniques for analysis of antigen-specific CD8+ T cell responses after nanoparticle vaccination.

Authors:  Lukasz J Ochyl; James J Moon
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

5.  Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles.

Authors:  Michael Chorny; Elizabeth Hood; Robert J Levy; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2010-05-18       Impact factor: 9.776

6.  Polymeric Nanocarrier Formulations of Biologics Using Inverse Flash NanoPrecipitation.

Authors:  Chester E Markwalter; Robert F Pagels; Ava N Hejazi; Akiva G R Gordon; Alexandra L Thompson; Robert K Prud'homme
Journal:  AAPS J       Date:  2020-01-02       Impact factor: 4.009

Review 7.  Polymeric nanoparticle technologies for oral drug delivery.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-27       Impact factor: 11.382

8.  Enzymatic protection and biocompatibility screening of enzyme-loaded polymeric nanoparticles for neurotherapeutic applications.

Authors:  Rick Liao; Jessica Pon; Michael Chungyoun; Elizabeth Nance
Journal:  Biomaterials       Date:  2020-07-15       Impact factor: 12.479

9.  Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.

Authors:  Eric M Pridgen; Frank Alexis; Timothy T Kuo; Etgar Levy-Nissenbaum; Rohit Karnik; Richard S Blumberg; Robert Langer; Omid C Farokhzad
Journal:  Sci Transl Med       Date:  2013-11-27       Impact factor: 17.956

Review 10.  Electrohydrodynamics: A facile technique to fabricate drug delivery systems.

Authors:  Syandan Chakraborty; I-Chien Liao; Andrew Adler; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2009-08-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.